With demand far outpacing supply, can manufacturers and regulators keep up with the “trendification” of these treatments – or will patient safety be the cost of their newfound fame?

Viagra, stimulants, smart drugs and prescription-only medicines are all ... at significantly lower prices to entice buyers. You win the auction, and send the money, but the transaction is rejected.

An MIT economist reveals why short-term fixes fail, and offers a blueprint for a complete system transformation. America’s Healthcare Emergency: How to Fix It From the Ground Up originally appeared on ...

Libido low and phallus soft? For men suffering from erectile dysfunction (ED), the solution may be one of these natural ...

Once hailed as a blue miracle for erectile dysfunction sufferers worldwide, Viagra ... UK within the next five years after its triumphant launch in Canada, offering 50mg dose pouches comparable in ...

Hims Hard Mints are a discreet alternative to erectile dysfunction pills. They’re created by a process called compounding. Compounded medications are customized or altered to meet a specific ...

The impotence drug Viagra could lead to blood clots and may be dangerous in those already at risk of a heart attack and stroke, it has emerged. A study suggests that Viagra can encourage blood ...

Red grape juice could be a drug-free alternative to Viagra ... UK to some degree. The NHS issues more than four million prescriptions a year for libido-boosting drugs such as Viagra, at a cost ...

Telemedicine and virtual healthcare visits are another noteworthy trend fueled by technology that can help lower patient costs associated with prescription medication. In part accelerated by the ...

Many of these supplements contain hidden ingredients or contaminants. Unlike prescription medications for ED such as Viagra, Cialis, and Levitra, these supplements are not Food and Drug ...

Let’s keep this between ourselves... Ah, if only Wegovy — the “Viagra of weight loss”, apparently — was as easy to obtain as its, erm, stimulating predecessor.

The prescription drug costs bill requires insurance companies to eliminate cost-sharing requirements for one generic drug and to cap co-payments on one brand-name drug at $25 per 30-day supply for ...